Arterex describes itself as a multi-capability medical device contract manufacturing platform resulting from the combination of NextPhase, Formula Plastics, Kabo, Luc & Bel, and ModenPlast. The company produces Class I, II, and III disposable and electromechanical devices at eight facilities across the United States, Mexico, Italy, and Egypt.

The Informa Markets Engineering network of B2B media sites includes Design News, Battery Technology, Medical Device & Diagnostic Industry (MD+DI), Packaging Digest, PlasticsToday, and Powder & Bulk Solids.

"Micromold brings with it over 40 years of expertise from mold design to end customer fulfillment services that allows us to expand our services and capabilities to our growing customer base,” said Arterex President for North America, Bill Gerard. “The company is an ideal addition to our offering of high-quality precision injection molded medical components, assemblies, and product design and development services.”

Micromold will continue injection molding plastic parts for medical device OEMs from Arterex’s FDA-registered facility in Mexico.

“As our global customer base for hot-runner and controller systems continues to grow so does the complexity of the molded parts for which we help find solutions,” said Stafano Mirti, Husky’s President of Hot Runners and Controllers. “I’m very excited about where we are taking our business and how this significant technology investment will enable us to support our customers and help them to grow their businesses. Our new manufacturing line will enable shorter lead times and provide even more capability to produce highly repeatable manifolds of the best quality.”

Husky currently produces hot runners and controllers on three continents in more than 54,000 square meters of manufacturing space. Additional investments are planned for hot runner manufacturing in its U.S. and China facilities. Husky’s goal is to be the industry’s first choice for melt delivery systems, as seen by its innovative approach to reducing sources of waste and variability in the injection molding process.

Until she retired in September 2021, Clare Goldsberry reported on the plastics industry for more than 30 years. In addition to the 10,000+ articles she has written, by her own estimation, she is the author of several books, including The Business of Injection Molding: How to succeed as a custom molder and Purchasing Injection Molds: A buyers guide. Goldsberry is a member of the Plastics Pioneers Association. She reflected on her long career in "Time to Say Good-Bye."

Husky Injection Molding Systems (Bolton, ON, Canada), a global provider of injection molding technology, equipment and services to the plastics industry, announced that a state-of-the-art, automated manufacturing line is now in operation at its Luxembourg facility. This is the third straight year that Husky has made a significant investment in new manufacturing equipment to support its growing base of hot runner and controller customers. In January of this year, Husky began producing hot-runner manifolds on one of the most advanced automated manufacturing lines in the industry, said Husky’s release.

Micromold will transfer its 24/7 operations to a 3,000-square-foot Class 8 cleanroom in Arterex’s Formula Plastics division in Tecate, Mexico. Micromold will continue to serve the medical, diagnostics, optical, dental, and laboratory markets, working under the ISO 13485:2016 quality system, said Arterex in the news release. The facility is registered with FDA.

Medical device developer and contract manufacturer Arterex has announced the acquisition of Micromold Inc. Riverside, CA–based Micromold has been supplying custom precision micro-molded plastic parts to medical device OEMs since 1984. The company is equipped with 20 Boy injection molding machines ranging from 10 to 33 tons in vertical and horizontal configurations.